FDA puts partial hold on Gilead ’s CD47 hopeful in AML
The FDA put a partial clinical hold on Gilead’s magrolimab for acute myeloid leukemia, a month after the company scrapped late-stage development of the CD47 candidate in myelodysplastic syndromes. Gilead said Monday morning it stopped screening and enrolling new patients in US…#fda #gilead #aml #partial #azacitidine #gileadsexpanded #unlock (Source: Reuters: Health)
Source: Reuters: Health - August 21, 2023 Category: Consumer Health News Source Type: news
Goodbye, Cheems: Iconic Dogecoin Meme Pooch Succumbs To Leukemia At Age 12
The sudden death of “Cheems,” the beloved Shiba Inu dog who became a viral meme, has left the internet world in mourning. The famous dog, who went by its real name “Pup Balltze,” won over the hearts of internet users all over the world because of its cuteness and lovability. Cheems became famous…#cheems #shibainu #pupballtze #dogecoin #hongkong #internetstar #nft #faceofdogecoineven #kabosu #elonmusk (Source: Reuters: Health)
Source: Reuters: Health - August 20, 2023 Category: Consumer Health News Source Type: news
Risks for MDS/Leukemia Increased for Survivors of Common Lymphoid Neoplasms
THURSDAY, Aug. 17, 2023 -- Survivors of common lymphoid neoplasms (LNs) have increased risks for therapy-related myelodysplastic syndrome/acute myeloid leukemia (tMDS/AML), although risks have been lower in more recent years, according to a study... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 17, 2023 Category: Pharmaceuticals Source Type: news
The family torn apart by cancer: Father, 53, who lost all THREE of his children to brain tumors and leukemia dies from disease - leaving behind his wife
Regis Feitosa Mota, 53,[left] from Fortaleza had battled off cancer three times since 2016. But in January this year he was diagnosed with the blood cancer multiple myeloma. (Source: the Mail online | Health)
Source: the Mail online | Health - August 16, 2023 Category: Consumer Health News Source Type: news
Pennsylvania Study Suggests Links Between Fracking and Asthma, Lymphoma in Children
[time-brightcove not-tgx=”true”]
(HARRISBURG, Pa.) — Children who lived closer to natural gas wells in heavily drilled western Pennsylvania were more likely to develop a relatively rare form of cancer, and nearby residents of all ages had an increased chance of severe asthma reactions, researchers said in reports released Tuesday evening.
The taxpayer-funded research by the University of Pittsburgh adds to a body of evidence suggesting links between the gas industry and certain health problems.
In the reports, the researchers found what they called significant associations between gas industry acti...
Source: TIME: Health - August 16, 2023 Category: Consumer Health News Authors: MARC LEVY / AP Tags: Uncategorized healthscienceclimate wire Source Type: news
Mayo Clinic Q and A: 5 advances in cancer treatment
DEAR MAYO CLINIC: In the past year, several family members have been diagnosed with various types of cancer, including leukemia, melanoma, breast cancer and colon cancer. In talking about treatments, it seems as if there is more available today than in the past. Can you share some of the advances in cancer care? What should I know as far as my risk for cancer? ANSWER: Although the rate of cancer diagnosis has fallen slightly post-COVID-19, cancer remains… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - August 15, 2023 Category: Databases & Libraries Source Type: news
BTKi Combo Strong Option in CLL BTKi Combo Strong Option in CLL
A new interim analysis finds more evidence that ibrutinib plus rituximab is a viable option for younger patients with untreated chronic lymphocytic leukemia compared with standard chemoimmunotherapy.MDedge News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - August 9, 2023 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
VANFLYTA (quizartinib), FDA Approved in the U.S. for Newly Diagnosed FLT3-ITD Positive Acute Myeloid Leukemia, Available at Biologics by McKesson
CARY, N.C., Aug. 4, 2023 — Biologics by McKesson, an independent specialty pharmacy specializing in oncology and rare diseases, was selected by Daiichi Sankyo, Inc., as a specialty pharmacy provider for VANFLYTA® (quizartinib). VANFLYTA is indicated for use in combination with standard cytarabine an... (Source: McKesson News)
Source: McKesson News - August 4, 2023 Category: Information Technology Source Type: news
New Diagnostic Tests Could Change The Landscape For Leukemia Prevention And Treatment
A Montana based molecular diagnostic company, Alercell Inc., is pioneering novel techniques to augment the way leukemia is diagnosed, treated and ultimately prevented. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - August 3, 2023 Category: Pharmaceuticals Authors: Omer Awan, Contributor Tags: Healthcare /healthcare Innovation /innovation standard Source Type: news
FDA approves gilteritinib for relapsed or refractory acute myeloid leukemia (AML) with a FLT3 mutation
On November 28, 2018, the Food and Drug Administration approved gilteritinib (XOSPATA, Astellas Pharma US Inc.) for treatment of adult patients who have relapsed or refractory acute myeloid leukemia (AML) with a FLT3 mutation as detected by an FDA-approved test. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - July 31, 2023 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Leukemia With IKZF ₁ Deletion Benefits From Prolonged Maintenance Therapy
MONDAY, July 31, 2023 -- For children with acute lymphoblastic leukemia (ALL), cases with IKZF ₁ deletion (IKZF₁del) benefit from prolonged maintenance therapy, according to a study published online July 17 in the Journal of Clinical... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 31, 2023 Category: Pharmaceuticals Source Type: news
Little-known symptom that doctors say could be a sign of cancer - it appears on sheets and pillows every morning
As record-high temperatures spread across the US, night sweats are becoming more common. In rare cases, they could be a sign of certain cancers, such as leukemia. (Source: the Mail online | Health)
Source: the Mail online | Health - July 28, 2023 Category: Consumer Health News Source Type: news
Episode 3: Developments and Challenges in Chronic Myeloid Leukemia Episode 3: Developments and Challenges in Chronic Myeloid Leukemia
Drs Michael J. Mauro and Jorge E. Cortes discuss developments in the therapeutic landscape of chronic myeloid leukemia, complexities of resistance, and the potential for treatment-free remission.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 27, 2023 Category: Consumer Health News Tags: Hematology-Oncology InDiscussion Source Type: news
‘Miracle Mineral Solution’ Case: 4 Florida Men Convicted Of Selling Bleach Treatment
They had claimed that MMS, which can turn into bleach, can cure 95% of the world ’s known illnesses, including HIV/AIDS, autism, leukemia, and Covid-19. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - July 23, 2023 Category: Pharmaceuticals Authors: Bruce Y. Lee, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation Science /science business pharma standard Source Type: news
FDA approves Daiichi Sankyo's new first-line AML drug quizartinib with boxed warning for heart disorders
Patients with a rarer form of acute myeloid leukemia now have a frontline treatment option for the first time, thanks to the FDA’s approval of Vanflyta (quizartinib), Daiichi Sankyo announced late Thursday. Vanflyta has been approved for FLT3-ITD-positive AML patients in…#myeloid #fda #daiichisankyo #aml #unlock (Source: Reuters: Health)
Source: Reuters: Health - July 21, 2023 Category: Consumer Health News Source Type: news
